Strength
250 mg/1
Manufacturer
Method Pharmaceuticals LLCNDC
58657093301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA070772On Market Since
7/1/2025
Pharmacological Classes
Nitroimidazole Antimicrobial
Nitroimidazoles
Related Drugs
Same classification
METRONIDAZOLE 250 MG TABLET
Generic
00904715661•Major Pharmaceuticals
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
16571066501•Rising Pharma Holdings Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
16571066550•Rising Pharma Holdings Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
23155065101•Heritage Pharmaceuticals Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
23155065105•Heritage Pharmaceuticals Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
29300022601•Unichem Pharmaceuticals (USA) Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
29300022605•Unichem Pharmaceuticals (USA) Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
29300022652•Unichem Pharmaceuticals (USA) Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
50111033301•Teva Pharmaceuticals USA Inc.
$0.0791
per EA
METRONIDAZOLE 250 MG TABLET
Generic
50111033302•Teva Pharmaceuticals USA Inc.
$0.0791
per EA